Normothermia for Pediatric and Congenital Heart Surgery: An Expanded Horizon by Ahmad Mahir Shamsuddin et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PEDIATRICS
MINI REVIEW ARTICLE
published: 28 April 2015
doi: 10.3389/fped.2015.00023
Normothermia for pediatric and congenital heart surgery:
an expanded horizon
Ahmad Mahir Shamsuddin1*, Ahmad Mohd Nikman2, Saedah Ali 2, Mohd Rizal Mohd Zain3,
Abdul RahimWong4 and Antonio Francesco Corno1,3†
1 Pediatric and Congenital Cardiac Surgery Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
2 Department of Anesthesia, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
3 Department of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
4 Pediatric Cardiology, Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia
Edited by:
Oswin Grollmuss, Centre Chirurgical
Marie Lannelongue, France
Reviewed by:
Yves Durandy, Centre Chirurgical
Marie-Lannelongue, France
Tsvetomir Loukanov, University of
Heidelberg, Germany
*Correspondence:
Ahmad Mahir Shamsuddin, Pediatric
and Congenital Cardiac Surgery Unit,
Department of Surgery, School of
Medical Sciences, Universiti Sains
Malaysia, Health Campus, Kubang
Kerian, Kelantan 16150, Malaysia
e-mail: amahir@gmail.com
†Present address:
Antonio Francesco Corno, East
Midlands Congenital Heart Centre,
Glenfield Hospital, Leicester, UK
e-mail: tonycorno2@gmail.com
Cardiopulmonary bypass (CPB) in pediatric cardiac surgery is generally performed with
hypothermia, flow reduction and hemodilution. From October 2013 to December 2014, 55
patients, median age 6 years (range 2 months to 52 years), median weight 18.5 kg (range
3.2–57 kg), underwent surgery with normothermic high flow CPB in a new unit.There were
no early or late deaths. Fifty patients (90.9%) were extubated within 3 h, 3 (5.5%) within
24 h, and 2 (3.6%) within 48 h. Twenty-four patients (43.6%) did not require inotropic sup-
port, 31 (56.4%) received dopamine or dobutamine: 21≤5 mcg/kg/min, 8 5–10 mcg/kg/min,
and 2 >10 mcg/kg/min. Two patients (6.5%) required noradrenaline 0.05–0.1 mcg/kg/min.
On arrival to ICU and after 3 and 6 h and 8:00 a.m. the next morning, mean lactate lev-
els were 1.9±09, 2.0±1.2, 1.6±0.8, and 1.4±0.7 mmol/L (0.6–5.2 mmol/L), respectively.
From arrival to ICU to 8:00 a.m. the next morning mean urine output was 3.8±1.5 mL/kg/h
(0.7–7.6 mL/kg/h), and mean chest drainage was 0.6±0.5 mL/kg/h (0.1–2.3 mL/kg/h). Mean
ICU and hospital stay were 2.7±1.4 days (2–8 days) and 7.2±2.2 days (4–15 days), respec-
tively. In conclusion, normothermic high flow CPB allows pediatric and congenital heart
surgery with favorable outcomes even in a new unit. The immediate post-operative period
is characterized by low requirement for inotropic and respiratory support, low lactate pro-
duction, adequate urine output, minimal drainage from the chest drains, short ICU, and
hospital stay.
Keywords: cardiopulmonary bypass, congenital heart defects, congenital and pediatric heart surgery, hemodilution,
high flow, modified ultrafiltration, normothermia, surgical outcomes
INTRODUCTION
Cardiopulmonary bypass (CPB) for pediatric cardiac surgery
is generally performed with hypothermia, flow reduction, and
hemodilution. The reasons historically given to justify the above
technique were to maintain low metabolic status during the oper-
ation, to gain maximum tissue protection during CPB, to have a
relatively safe margin in situation of unexpected difficulties, and
to provide adequate surgical exposure (1).
A large number of hospitals are still using the technique of
deep hypothermia with circulatory arrest, justified by reduced
duration of CPB in small infants, simplified cannulation and unen-
cumbered operative field particularly for infants with anomalous
venous connections (2).
However, the use of hypothermic CPB with flow reduction
and hemodilution is associated with major side effects, with neg-
ative influence on the patients’ outcomes. Because of this rea-
son several hospitals, at least in Europe, have moved toward the
use of normothermia for pediatric and congenital heart surgery
(1, 3, 4).
In a new unit like ours, with its inherent difficulties because of
new staff and the lack of training available in a developing country,
normothermic high flow CPB was introduced for pediatric and
congenital heart surgery.
The aim of this prospective study was to analyze the results of
the initial experience.
MATERIALS AND METHODS
From October 2013 to December 2014, 97 consecutive patients,
median age 3.6 years (range 27 days to 52 years), with median
body weight 12.1 kg (range 800 g to 62 kg), underwent surgery
for pediatric and congenital heart defects in our new unit.
Criteria for exclusion from this study were operation performed
without the use of CPB or operation performed with the use of
even a mild degree of hypothermia (<35°C).
Fifty-five consecutive patients (55/97= 57%), median age
6.0 years (range 2 months to 52 years), with median body weight
18.5 kg (range 3.2–57.0 kg), underwent surgery with normoth-
ermic high flow CPB and were prospectively included in the
study.
Forty-two patients (42/97= 43%) were excluded from the
study because they were operated on either without CPB (40
patients) or because the operation required CPB with a period
of hypothermia (<35°C) because of aortic surgery with flow
reduction (2 patients).
The study was approved by the hospital ethical committee and
parental informed consent was obtained for all patients.
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CPB PROTOCOL
The standard protocol for CPB was the following:
• priming with leukocyte-depleted blood (when blood required)
• controlled reoxygenation (5–9) in cyanotic patients with pre-
operative oxygen saturation ≤85%
• normothermia: nasopharynx and rectal temperature main-
tained between 35.0 and 36.5°C
• high flow:≥3.0 L/m2 BSA/min
• hematocrit ≥30%, aiming at a value at least 40% by the end
of CPB
• mixed venous oxygen saturation ≥65%
• cold blood cardioplegia administered every 20 min
• modified ultrafiltration (10–15 mL/kg) at the end of CPB
• administration of I.V. milrinone (0.3 mcg/kg/min) from the end
of CPB
• administration of I.V. calcium gluconate (300 mg/kg/day) on
arrival to ICU
• administration of I.V. frusemide (1–2 mg/kg/day) on arrival
to ICU
Diagnoses and the surgical procedures are listed in Tables 1
and 2.
The Basic and Comprehensive Aristotle Score (10) were used
to assess the potential mortality and morbidity in our patient
population.
DATA COLLECTION
All database regarding patients operated with normothermic CPB
were prospectively recorded.
The overall outcomes of the operation included: survival, need
for re-operation, ICU, and hospital stays.
Intra-operative data included duration of CPB and aortic
cross-clamp, need for inotropic support, lactate level, and urine
output.
Post-operative data included duration of mechanical venti-
lation, and type, dosage and duration of inotropic support; in
addition lactate level, urine output, and chest drains bleeding were
recorded on arrival to ICU, after 3 and 6 h, and at 8:00 a.m. of the
first post-operative day.
Our hospital does not have an intermediate step-down unit,
and therefore the patients were discharged from ICU only when
they were off ventilatory support, inotropes, and chest drains, and
were transferred to the normal ward.
Data were expressed as mean± SD.
RESULTS
The mean Basic Aristotle score (scale 1–5) was 3.1± 0.8 (range 1–
5) and the mean Comprehensive Aristotle score (scale 1–10) was
6.2± 1.7 (range 3–10).
There were no early or late deaths until the end of the follow-up
period (December 2014).
Not one patient had clinically evident neurological deficit, and
only one patient (1/55= 1.8%) with Down syndrome required re-
operation because of wound infection caused by Staphylococcus
aureus after repair of Tetralogy of Fallot.
Table 1 | List of diagnosis and associated defects.
Number of
cases
Diagnosis Associated defects
24 Ventricular septal defects 9 AoV Regurgitation
18 DCJA 7 RVOTO
2 Perimembranous 7 Subaortic obstruction
4 Multiple VSDs
8 Atrial septal defect 4 MV Regurgitation
1 Borderline LV
1 Dislodged occlusion
device
4 MV regurgitation 3 AoV regurgitation
1 TV regurgitation
5 Tetralogy of Fallot
4 AVSD 3 partial
1 Complete
3 Anomalous pulmonary venous
connection
2 partial
1 Total
2 Obstructed RV-PA conduit
1 RVOTO s/p TF repair elsewhere
1 DORV, VSD, TGA, PS
1 Mitral atresia
DORV
Hypoplastic LV
Restrictive inter-atrial
communication
1 Situs inversus
Dextrocardia
Univentricular Heart
Bilateral superior vena cava
Right aortic arch
1 DORV, severe PS, VSD,
hypoplastic PAs, right aortic arch
AoV, aortic valve; ASD, atrial septal defect; AVSD, atrio-ventricular septal defect,
DCJA, doubly committed juxta-arterial, DORV, double outlet right ventricle, LV,
left ventricle, MV, mitral valve, PA, pulmonary artery; PS, pulmonary stenosis;
RV, right ventricle; RVOTO, right ventricular outflow tract obstruction; TGA, trans-
posed great arteries; TV, tricuspid valve; TF, Tetralogy of Fallot; VSD, ventricular
septal defect.
Mean CPB time and aortic cross-clamp time were respec-
tively 94± 43 min (range 45–288 min) and 46± 24 min (range
0–102 min).
Fifty patients (50/55= 90.9%) were weaned from mechani-
cal ventilation and extubated within 3 h from ICU arrival, three
(3/55= 5.5%) within 24 h, and two (2/55= 3.6%) within 48 h.
Twenty-four patients (24/55= 43.6%) did not require
inotropic support. Thirty-one patients (31/55= 56.4%) received
dopamine or dobutamine post-operatively: 21 of them
(21/31= 67.7%) received dopamine or dobutamine ≤5 mcg/kg/
min, 8 (8/31= 25.8%) received 5–10 mcg/kg/min, and 2
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Table 2 | List of surgical procedures.
Number of
procedures
Surgical procedures Additional procedures
24 VSD closure 7 RVOT reconstruction
7 Subaortic resection
with septal myectomy
2 AoV repair
8 ASD closure 4 MV repair
1 Device removal
4 MV repair 1 MV replacement
1 AoV repair
1 TV repair
5 TF repair 1 RV–PA conduit
4 AVSD repair
3 Repair of anomalous pulmonary
venous connection
2 Conduit replacement
1 RVOT reconstruction with RV-PA
conduit
1 Intracardiac repair of DORV, VSD,
TGA, PS
1 Atrioseptectomy, main PA division,
Bidirectional Glenn
1 Atrioseptectomy, main PA division,
bilateral bidirectional Glenn
1 modified Blalock-Taussig shunt
on CPB
AoV, aortic valve; ASD, atrial septal defect; AVSD, atrio-ventricular septal defect;
CPB, cardiopulmonary bypass; DORV, double outlet right ventricle; MV, mitral
valve; PA, pulmonary artery; PS, pulmonary stenosis; RV, right ventricle; RVOT,
right ventricular outflow tract; TF, Tetralogy of Fallot; TGA, transposed great
arteries; TV, tricuspid valve; VSD, ventricular septal defect.
(2/31= 6.5%) required >10 mcg/kg/min. Two patients (2/31=
6.5%) required additional noradrenaline 0.05–0.1 mcg/kg/min.
Mean lactate level at arrival to ICU, after 3 h, after 6 h and 08:00
a.m. next morning was respectively 1.9± 09, 2.0± 1.2, 1.6± 0.8,
and 1.4± 0.7 mmol/L (range 0.6–5.2 mmol/L).
Mean urine output from ICU arrival to 08:00 a.m. next
morning was 3.8± 1.5 mL/kg/h (range 0.7–7.6 mL/kg/h).
Mean chest drains bleeding from ICU arrival to 08:00 a.m. next
morning was 0.6± 0.5 mL/kg/h (range 0.1–2.3 mL/kg/h).
Mean ICU and hospital stays were respectively 2.7± 1.4 days
(range 2–8 days) and 7.2± 2.2 days (range 4–15 days).
DISCUSSION
Hypothermic CPB with hemodilution was introduced in pediatric
cardiac surgery with the aims of decreasing the oxygen consump-
tion and improving the distal body perfusion with the decreased
blood viscosity due to hemodilution (1, 3, 4). With the introduc-
tion of surgical repair of more complex congenital heart defects
in small infants, the hypothermic CBP with flow reduction, and
even deep hypothermia with circulatory arrest, gained widespread
application because of the adequate surgical exposure allowed by
the absence of blood and venous cannulas in the small operative
field (1, 2, 4, 11, 12).
Despite the good results obtained with hypothermic CPB,
allowing the surgical repair of more complex congenital heart
defects, over the years a large series of experimental and clinical
studies reported extensive negative effects of hypothermia and flow
reduction associated with hemodilution (1, 3, 4, 12–34), which are
the following:
AT THE CELLULAR LEVEL
Decreased ATP levels were observed, as well as increased anaerobic
metabolism, decreased intracellular pH, increased lactate produc-
tion, decreased glycogen level, decreased efficiency of membrane-
based ion pumps, increased cell swelling, decreased mitochondrial
function, increased Calcium influx, and decreased intracellular
enzyme function.
These damages mainly occur in the parenchymal cells (neu-
rons and myocytes), the endothelial cells (systemic and pulmonary
vascular systems), and the inflammatory cells (inflammatory
response, ischemia/reperfusion injury).
AT THE TISSUE LEVEL
The metabolic and hormonal systems are affected in rela-
tion to blood glucose, adrenal stress response, level of cir-
culating adrenaline and noradrenaline, release of insulin and
peripheral utilization of glucose, serum potassium, release of
neurotransmitters in response to ischemia, ability of receptors
to bind and take up noradrenaline, complement activation,
release of angiotensin, interleukins, cytokines, beta-endorphines,
and anti-diuretic hormones. The vascular system is affected
by endothelial injury, decreased cardiac output, increased sys-
temic vascular resistance, renal vasoconstriction, and generalized
tissue edema.
In the myocardium, rapid cooling contracture can occur, and
the respiratory system can be affected by endothelial lung injury.
Renal function is impaired by decreased glomerular filtration,
decreased renal cortical blood flow because of renal vasoconstric-
tion with redistribution of intra-renal blood flow to the renal
medulla, and depressed tubular function.
Neurologic damages were reported because of increased cere-
bral vascular resistance, decreased cerebral blood flow, decreased
response to increase in CO2 tension, hypothalamic dysfunc-
tion (post-operative hyperthermia), appearance of choreoatheto-
sis, seizures, and overall vulnerability to brain injuries and
neurodevelopmental impairment.
The hematologic system is affected by left shift of the oxyhe-
moglobin dissociation curve, leukocyte aggregation and degranu-
lation, and platelet function defect (shape change, aggregation).
The overall clinical consequences complicating the outcomes
of pediatric and congenital heart surgery with conventional
hypothermic CPB with flow reduction and hemodilution are
low cardiac output syndrome (requiring inotropic support),
pulmonary dysfunction (requiring respiratory support), meta-
bolic derangement (with acidosis and renal failure), coagula-
tion derangement (with excessive chest bleeding), and neurologic
complications (with choreoathetosis, seizures, and neurodevelop-
mental impairment) (1, 3, 4, 12, 15, 18–24).
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All these negative reports derived from experimental and clin-
ical studies motivated the search for alternative modality for
perfusion in the pediatric population.
The two most important changes introduced in clinical prac-
tice were (1) the selective cerebral perfusion, in order to reduce the
negative neurologic consequences of the circulatory arrest accom-
panying deep hypothermia (2, 11, 12, 35–39); (2) the reduced
degree of hemodilution, with a higher hematocrit than used before
(31, 33, 34).
But the most evident modification of the conventional CPB
with hypothermia and hemodilution was the introduction of
normothermic high flow CPB with minimal hemodilution.
This technique of perfusion was first used in Paris, France, by
Lecompte and Durandy (40), who later reported in the literature
the use of their technique in a very large number of patients in
pediatric heart surgery (41, 42); the direct exposure to this expe-
rience persuaded other surgeons to introduce the same technique
in their clinical practice, and in few years the number of hospital
using normothermic high flow CPB with limited hemodilution
expanded across Europe (1, 3, 4, 43–49).
The basic principles are the use of high flow, with the pump flow
maintained≥3.0 L/m2 BSA/min, with the nasopharynx and rectal
temperature maintained between 35.0 and 36.5°C, and hematocrit
maintained≥30%. These conditions are more close to the normal
physiology, where the systemic flow is 3.0–5.5 L/m2 B.S.A./min,
the temperature 37°C, and the hematocrit 45%.
The pump flow used in conventional CBP is 2.0–2.4 L/m2
BSA/min or 100–120 mL/min/kg of body weight, even if it is
improperly called “full flow,” and frequently is further reduced
during the central part of the operation when requested by the
surgeon to facilitate the surgical exposure, or even to circulatory
arrest with deep hypothermia.
The combination of flow reduction, hypothermia, and hemod-
ilutaion are responsible for all the difficulties observed in the
post-operative course after pediatric and congenital heart surgery.
Additional modifications used in our experience, in addition
to the technique of normothermic high flow CPB with limited
hemodilution, were:
• priming with leukocyte-depleted blood (when blood required)
The use of leukocyte-depleted blood was long time ago demon-
strated to be one of the most important variable to reduce
the ischemia/reperfuson damage associated with the CPB
and the mycardial ischemia required for intracardiac repair
(50, 51).
• “controlled” reoxygenation
The damaged induced by the hypoxia/reoxygenation injury were
extensively studied with experimental and clinical studies (5–9,
52–61).
The technique of “controlled” reoxygenation was introduced
in the clinical practice after extensive animals’ studies. To
reduce the oxygenation damage, the arterial pO2 at the begin-
ning of CPB is slowly and progressively increased, reaching
the full reoxygenation after 5 min of full flow. This technique
was applied in our experience in all cyanotic patients with
pre-operative oxygen saturation ≤85%.
• modified ultrafiltration
The technique of modified ultrafiltration was introduced as one of
the methods to reduce the inflammatory response caused by the
CPB (62–69).
The mechanisms used by modified ultrafiltration are the fol-
lowing: removal of significant amounts of inflammatory medi-
ators (IL-1, IL-6, TNF-alpha, C3a, and C5a), removal of exces-
sive body water, and reduction in the quantity of circulating
endotoxins.
The observed clinical advantages provided by modified ultra-
filtration are improved intrinsic left ventricular systolic function,
increased systemic blood pressure, decreased pulmonary artery
pressure, and decreased requirement for inotropic and respiratory
support in the early post-operative period (62–73).
In our experience, we applied modified ultrafiltration at the
end of CPB in all patients, removing an amount of fluids between
10 and 15 mL/kg according to the clinical needs.
This study with normothermic high flow CPB has resulted in
favorable outcomes, even in our study population, represented by
patients with generally poor conditions because of malnutrition,
recurrent infections, and late referrals. Furthermore, the technique
has been introduced in a new unit, without any previous experi-
ence in pediatric cardiac surgery, and with all limitations due to
reduced manpower, limited resources, and a generalized low level
of expertise in the field.
Nevertheless, our patients had good results, with generally
short ICU and hospital stay, early extubation, low requirement of
inotropic support, low lactate production, adequate urine output,
and minimal drainage from the chest drains.
POTENTIAL CONCERNS
There are two potential concerns toward the use of normothermic,
high flow, high hematocrit, CPB:
(a) reduced margin of safety against potential incidents on CPB
(b) inadequate surgical exposure.
However, the advantages provided by this perfusion technique
in the post-operative recovery overcome by far the potential risk of
incidents (44, 45), and adequate exposure even in small cyanotic
neonates can be obtained with appropriate venous cannulation
and left heart venting (1, 40, 43–45).
With regard to all the neurologic complications reported by the
conventional CPB, the normothermic, high flow, high hematocrit,
CPB has been used with reported contradictory neurologic results,
from the safety in relationship to the neurodevelopmental status
(49) to the observation with comparison of pre-operative with
post-operative magnetic resonance imaging suggesting that nor-
mothermic perfusion is associated with few new lesions following
the surgical treatment (73).
LIMITATIONS OF THE STUDY
The main limitation of this study is the absence of a control group.
So far, no systematic randomized control trial has been per-
formed to support normothermic high flow CPB versus hypother-
mic CPB, but there is an increasing trend toward the use of nor-
mothermic CPB, and no major adverse effects have been reported
by any series on normothermic CPB.
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Randomized controlled clinical trials (70) are considered the
gold standard (71) and would help define which of the two
main techniques are superior; however, a prospective randomized
clinical trial is not easily feasible because of several reasons:
(a) huge variability among the patient populations with congen-
ital heart defects. For instance, the evaluation of the neurode-
velopmental outcome (70) should take into consideration a
substantial percentage of infants with pre-operative cerebral
abnormalities (72)
(b) standardization of surgical procedures, with endless variable
details, is very difficult to achieve
(c) minor or major differences in the post-operative values of
inflammatory markers, neurological status, requirement and
duration of inotropic and respiratory support, stay in ICU,
etc., are dependent upon several variables in the patient man-
agement, all inter-related and inter-dependent, not necessarily
correlated with the modality of CPB
(d) after having used the “normothermic, high flow, high hema-
tocrit” CPB, and having seen the advantages over the con-
ventional hypothermic techniques, with an extremely smooth
and “physiologic” post-operative course, to consider for the
patients a return to the hypothermic techniques has been
considered by all surgeons as undesirable or unethical
CONCLUSION
Normothermic high flow CPB, close to normal physiology, allows
pediatric and congenital heart surgery with favorable outcomes.
The immediate post-operative period is characterized by low
requirement for inotropic and respiratory support, low lactate pro-
duction, adequate urine output, minimal losses from chest drains,
short ICU, and hospital stay.
This CPB technique was introduced successfully in a new pedi-
atric cardiac service with previous or little experience in congenital
heart disease surgery.
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